2023 Form 5500 filing — Amneal Pharmaceuticals LLC And Subsidiaries 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241002151706NAL0004970787001) for Amneal Pharmaceuticals LLC And Subsidiaries 401(K) Plan, reported by Amneal Pharmaceuticals LLC under EIN 90-0186021 and plan number 001. It reports 3,581 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241002151706NAL0004970787001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Amneal Pharmaceuticals LLC
- EIN
- 90-0186021
- Plan number
- 001
- Location
- Brookhaven, NY
- Participants
- 3,581
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $235,020,320
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $235,020,320
- Employer contributions
- $10,114,377
- Participant contributions
- $20,016,730
- Total income / additions
- $66,512,680
- Benefits paid
- $16,111,036
- Administrative expenses
- $291,523
- Total expenses
- $16,452,349
- Net increase / (decrease)
- $50,060,331
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Fidelity Investments Institutional | RECORDKEEPER | $205,573 | $0 |
| Morgan Stanley Smith Barney LLC | INVESTMENT ADVISOR | $45,000 | not reported in the loaded dataset |
| Eisneramper Llp | ACCOUNTANT/AUDITOR | $40,950 | not reported in the loaded dataset |